Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease
Clinical trial NCT02760407 · COMPLETED
Trial details
- NCT number
- NCT02760407
- Sponsor
- R-Pharm International, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-06
- Primary completion
- 2019-08-02
- Enrollment
- 1648
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.